Time-dependent effects of arginine vasopressin V1 receptor inhibition on secondary brain damage after experimental brain injury

R. Trabold, S. Krieg & N. Plesnila
Objective: The pharmacological inhibition of Arginine-Vasopressin (AVP) V1a receptor is able to reduce the brain edema, intracranial pressure (ICP), secondary brain damage and also improves therefore the neurological function after experimental brain injury. The aim of the study was to identify the [for full text, please go to the a.m. URL]